Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: A double-blind, randomized, clinical trial

Clinical Infectious Diseases

Volumn 60, Issue 3, 2015, Pages 357-365

  Ouédraogo, André Lin ^a   Bastiaens, Guido J H ^b   Tiono, Alfred B ^a   Guelbéogo, Wamdaogo M ^a   Kobylinski, Kevin C ^c,d   Ouédraogo, Alphonse ^a   Barry, Assata ^a   Bougouma, Edith C ^a   Nebie, Issa ^a   Ouattara, Maurice San ^a   Lanke, Kjerstin H W ^b   Fleckenstein, Lawrence ^e   Sauerwein, Robert W ^b   Slater, Hannah C ^f   Churcher, Thomas S ^f   Sirima, Sodiomon B ^a   Drakeley, Chris ^g   Bousema, Teun ^b,g  

^a Burkina Faso   (Burkina Faso)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^e UNIVERSITY OF IOWA   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

falciparum; gametocyte; sporogony; survivorship; transmission

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; IVERMECTIN; PLACEBO; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; INSECTICIDE;

ABDOMINAL PAIN; ABSCESS; ADOLESCENT; ADULT; ANOPHELES FUNESTUS; ANOPHELES GAMBIAE; ARTICLE; BODY MASS; BRONCHITIS; CONJUNCTIVITIS; CONTROLLED STUDY; COUGHING; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; GAMETOCYTE; HEADACHE; HUMAN; INFECTION RATE; LEG SWELLING; MAJOR CLINICAL STUDY; MALARIA; MALE; ORCHITIS; OUTCOME ASSESSMENT; PARASITE SURVIVAL; PHARYNGITIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SINGLE DRUG DOSE; THROMBOCYTE COUNT; TOOTH PAIN; URINARY TRACT INFECTION; ANIMAL; DRUG COMBINATION; MALARIA, FALCIPARUM; MOSQUITO; TRANSMISSION;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CULICIDAE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INSECTICIDES; IVERMECTIN; MALARIA, FALCIPARUM; MALE;

EID: 84922433986     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu797     Document Type: Article

References (27)

1. Meis JF, Wismans PG, Jap PH, Lensen AH, Ponnudurai T. A scanning electron microscopic study of the sporogonic development of Plasmodium falciparum in Anopheles stephensi. Acta Trop 1992; 50: 227-36
2. Sawa P, Shekalaghe SA, Drakeley CJ, et al. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. J Infect Dis 2013; 207: 1637-45
3. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361: 455-67
4. Dondorp AM, Fairhurst RM, Slutsker L, et al. The threat of artemisininresistant malaria. N Engl J Med 2011; 365: 1073-5
5. White NJ. Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis 2013; 13: 175-81
6. Coulibaly B, Zoungrana A, Mockenhaupt FP, et al. Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS One 2009; 4: e5318
7. Eziefula AC, Bousema T, Yeung S, et al. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, doubleblind, dose-ranging trial. Lancet Infect Dis 2014; 14: 130-9
8. Chaccour C, Lines J, Whitty CJ. Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control. J Infect Dis 2010; 202: 113-6
9. Sylla M, Kobylinski KC, Gray M, et al. Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wildcaught, blood fed malaria vectors. Malar J 2010; 9: 365
10. Kane NS, Hirschberg B, Qian S, et al. Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. Proc Natl Acad Sci U S A 2000; 97: 13949-54
11. Borrmann S, Sallas WM, Machevo S, et al. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria. Trop Med Int Health 2010; 15: 434-41
12. Ouedraogo AL, Guelbeogo WM, Cohuet A, et al. A protocol for membrane feeding assays to determine the infectiousness of P. falciparum naturally infected individuals to Anopheles gambiae. Malar World J 2013; 4: 16
13. Bell AS, Ranford-Cartwright LC. A real-Time PCR assay for quantifying Plasmodium falciparum infections in the mosquito vector. Int J Parasitol 2004; 34: 795-802
14. Stone WJ, Eldering M, van Gemert GJ, et al. The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays. Sci Rep 2013; 3: 3418
15. Wahajuddin , Singh SP, Jain GK. Determination of lumefantrine in rat plasma by liquid-liquid extraction using LC-MS/MS with electrospray ionization: assay development, validation and application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 1133-9
16. Kitzman D, Wei SY, Fleckenstein L. Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies. J Pharm Biomed Anal 2006; 40: 1013-20
17. Bousema T, Dinglasan RR, Morlais I, et al. Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PLoS One 2012; 7: e42821
18. Baraka OZ, Mahmoud BM, Marschke CK, Geary TG, Homeida MM, Williams JF. Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus. Eur J Clin Pharmacol 1996; 50: 407-10
19. Chaccour CJ, Kobylinski KC, Bassat Q, et al. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J 2013; 12: 153
20. Bastiaens GJH, van Gemert GJ, Hooghof J, et al. Duration of the mosquitocidal effect of ivermectin. Malar World J 2012; 3: 10
21. Vanapalli SR, Chen Y, Ellingrod VL, et al. Orange juice decreases the oral bioavailability of ivermectin in healthy volunteers. Clin Pharmacol Ther 2003; 73: 94
22. Olsen A. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-Transmitted helminthiasis, lymphatic filariasis and onchocerciasis. Trans R Soc Trop Med Hyg 2007; 101: 747-58
23. Guzzo CA, Furtek CI, Porras AG, et al. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol 2002; 42: 1122-33
24. Awadzi K, Opoku NO, Addy ET, Quartey BT. The chemotherapy of onchocerciasis. XIX: the clinical and laboratory tolerance of high dose ivermectin. Trop Med Parasitol 1995; 46: 131-7
25. Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 1997; 350: 18-22
26. Kobylinski KC, Sylla M, Chapman PL, Sarr MD, Foy BD. Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages. Am J Trop Med Hyg 2011; 85: 3-5
27. Slater HC, Walker PG, Bousema T, Okell LC, Ghani AC. The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study. J Infect Dis 2014; 210: 1972-80